{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T04:09:11Z","timestamp":1787890151580,"version":"build-2784847793"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T00:00:00Z","timestamp":1628467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T00:00:00Z","timestamp":1628467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s00592-021-01776-w","type":"journal-article","created":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T07:03:18Z","timestamp":1628492598000},"page":"1575-1577","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Treating hypercholesterinemia in a patient with maternally inherited diabetes and deafness (MIDD) by the proprotein convertase subtilisin\/kexin type 9 (PCSK9) inhibitor alirocumab"],"prefix":"10.1007","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5301-1163","authenticated-orcid":false,"given":"Bernd","family":"Schultes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian M.","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,9]]},"reference":[{"key":"1776_CR1","doi-asserted-by":"publisher","first-page":"241","DOI":"10.4158\/EP-2019-0270","volume":"26","author":"KN Robinson","year":"2020","unstructured":"Robinson KN, Terrazas S, Giordano-Mooga S, Xavier NA (2020) The role of heteroplasmy in the diagnosis and management of maternally inherited diabetes and deafness. Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol 26:241\u2013246. https:\/\/doi.org\/10.4158\/EP-2019-0270","journal-title":"Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol"},{"key":"1776_CR2","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1016\/j.jdiacomp.2017.04.001","volume":"31","author":"J Zhu","year":"2017","unstructured":"Zhu J, Yang P, Liu X et al (2017) The clinical characteristics of patients with mitochondrial tRNA Leu(UUR)m.3243A > G mutation: compared with type 1 diabetes and early onset type 2 diabetes. J Diabetes Complicat 31:1354\u20131359. https:\/\/doi.org\/10.1016\/j.jdiacomp.2017.04.001","journal-title":"J Diabetes Complicat"},{"key":"1776_CR3","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.jdiacomp.2014.03.006","volume":"28","author":"A Naing","year":"2014","unstructured":"Naing A, Kenchaiah M, Krishnan B, et al. (2014) Maternally inherited diabetes and deafness (MIDD): diagnosis and management. J Diabetes Complicat 28:542\u2013546. https:\/\/doi.org\/10.1016\/j.jdiacomp.2014.03.006","journal-title":"J Diabetes Complicat"},{"key":"1776_CR4","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1111\/dom.13384","volume":"20","author":"OP Ganda","year":"2018","unstructured":"Ganda OP, Plutzky J, Sanganalmath SK, et al. (2018) Efficacy and safety of alirocumab among individuals with diabetes mellitus and atherosclerotic cardiovascular disease in the ODYSSEY phase 3 trials. Diabetes Obes Metab 20:2389\u20132398. https:\/\/doi.org\/10.1111\/dom.13384","journal-title":"Diabetes Obes Metab"},{"key":"1776_CR5","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1111\/dom.13114","volume":"19","author":"LA Leiter","year":"2017","unstructured":"Leiter LA, Cariou B, M\u00fcller-Wieland D, et al. (2017) Efficacy and safety of alirocumab in insulin-treated individuals with type 1 or type 2 diabetes and high cardiovascular risk: the ODYSSEY DM-INSULIN randomized trial. Diabetes Obes Metab 19:1781\u20131792. https:\/\/doi.org\/10.1111\/dom.13114","journal-title":"Diabetes Obes Metab"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-021-01776-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00592-021-01776-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-021-01776-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T15:53:24Z","timestamp":1633967604000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00592-021-01776-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,9]]},"references-count":5,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["1776"],"URL":"https:\/\/doi.org\/10.1007\/s00592-021-01776-w","relation":{},"ISSN":["0940-5429","1432-5233"],"issn-type":[{"value":"0940-5429","type":"print"},{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,9]]},"assertion":[{"value":"1 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}